Lymphoma in 2020 and Beyond

Clinical experts from the US discuss global perspectives on current treatment strategies and emerging therapies for lymphomas: T-Cell, Hodgkin, MZL/Waldenström Macroglobulinemia, DLBCL, FL, and MCL.

September 29 & October 1, 2020
Purchase Report

FACULTY CHAIR

Brad S. Kahl, MD

Washington University School of Medicine

Faculty Members

Stefan Barta MD, MRCP, MS
University of Pennsylvania Health System, Philadelphia, PA

Paolo Caimi, MD
University Hospitals Case Medical Center, Cleveland, OH

Catherine Diefenbach, MD
Perlmutter Cancer Center NYU Langone,  New York City, NY

Kieron Dunleavy, MD
George Washington University Cancer Center, Washington DC

Nina Wagner-Johnston, MD
Johns Hopkins Hospital, Baltimore, MD

Peter Martin, MD
Weill Cornell Medicine/Cornell University, New York City, NY

Sample Report

Start discovering the insights

View Report

TOPICS COVERED IN THE UPCOMING REPORT

Clinical experts from across the US discuss global perspectives on current treatment strategies and emerging therapies for lymphomas: T-Cell, Hodgkin, MZL/Waldenström Macroglobulinemia, DLBCL, FL, and MCL.

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.